Caring for Patients Treated With Immune Checkpoint Inhibitors: Guidance and Resources for Nurses and Pharmacists

Review multidisciplinary guidance on the optimal care of patients receiving immune checkpoint inhibitors in the era of COVID-19. Get up to date on best practices in this challenging healthcare climate with downloadable slides and the on-demand Webcast capturing a dynamic live Webinar.
John Thompson Headshot
John A. Thompson, MD
Program Director
Stephanie Andrews, MS, ANP-BC
Marianne Davies, DNP, CNS, ACNP-BC, AOCNP
John Thompson Headshot
John A. Thompson, MD

On-Demand Webcast

Watch these focused expert presentations on clinical strategies for nurses and pharmacists caring for patients receiving ICIs, from educating patients to identifying and managing immune-related adverse events in the era of COVID-19.

John Thompson Headshot John A. Thompson, MD
Program Director
Stephanie Andrews, MS, ANP-BC Marianne Davies, DNP, CNS, ACNP-BC, AOCNP
Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 25, 2020 Expired: June 24, 2021

Downloadable Slidesets

Download this short summary slideset of clinical highlights for nurses and pharmacists caring for patients receiving immune checkpoint inhibitors today.

Stephanie Andrews, MS, ANP-BC Marianne Davies, DNP, CNS, ACNP-BC, AOCNP John Thompson Headshot John A. Thompson, MD Released: June 26, 2020

Download this slideset with key fundamentals for nurses and pharmacists on integrating immune checkpoint inhibitors into the care of patients with diverse malignancies.

John Thompson Headshot John A. Thompson, MD Released: May 1, 2020

Download this slideset with clinical strategies for nurses and pharmacists on preventing, anticipating, detecting, and treating immune-related adverse events.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Released: May 4, 2020

Download this slideset with insights for nurses and pharmacists on managing immune-related adverse events in special patient populations, treating steroid-refractory events, identifying the etiology of toxicity with ICI combination therapies, and delivering oncology care during COVID-19.

Stephanie Andrews, MS, ANP-BC Released: May 4, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue